NAMPT degrader-1

Catalog No. :
ACSBRS353
CAS No. :
3011778-39-2
Molecular Formula :
C56H68ClN9O5S2
Molecular Weight :
1046.81

IUPAC Name:(R)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methyl-N-(3-(9-(4-((4-(3-(pyridin-3-ylmethyl)thioureido)phenyl)sulfonyl)piperazin-1-yl)nonanamido)propyl)benzamide

NAMPT degrader-1 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameNAMPT degrader-1
IUPAC Name(R)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methyl-N-(3-(9-(4-((4-(3-(pyridin-3-ylmethyl)thioureido)phenyl)sulfonyl)piperazin-1-yl)nonanamido)propyl)benzamide
Molecular FormulaC56H68ClN9O5S2
Molecular Weight1046.81
SMILESCC1=CC=C(C(=O)N(CCCNC(=O)CCCCCCCCN2CCN(S(=O)(=O)C3=CC=C(NC(=S)NCC4=CC=CN=C4)C=C3)CC2)[C@@H](C2=NC3=C(C=CC(Cl)=C3)C(=O)N2CC2=CC=CC=C2)C(C)C)C=C1
InChI KeyLZCAADBODOWVEZ-OIVUAWODSA-N
SynonymNAMPT degrader-1;1-Piperazinenonanamide, N-[3-[[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl](4-methylbenzoyl)amino]propyl]-4-[[4-[[[(3-pyridinylmethyl)amino]thioxomethyl]amino]phenyl]sulfonyl]-
CAS No.3011778-39-2

Synthetic Route by SureRoute

1. ACSBRS353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWVSK201 route compound structure diagram
    ACWVSK201336113-53-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBRS353 route product structure diagram
    ACSBRS3533011778-39-2
Inquiry

2. ACSBRS353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBRS353 route product structure diagram
    ACSBRS3533011778-39-2
Inquiry

Comments (0)